Sintx Technologies (SINT) Total Non-Current Liabilities (2013 - 2026)
Sintx Technologies' (SINT) quarterly Total Non-Current Liabilities came in at $6.4 million in Q1 2026, up 22.67% year-on-year from $5.2 million in Q1 2025, and up 11.7% quarter-over-quarter from $5.8 million in Q4 2025.
Sintx Technologies (SINT) Total Non-Current Liabilities (2013 - 2026) Analysis & Trends
Sintx Technologies' Total Non-Current Liabilities history runs 14 years deep, the most recent figure standing at $6.4 million for Q1 2026.
- On a quarterly basis, Total Non-Current Liabilities rose 22.67% year-over-year to $6.4 million in Q1 2026; TTM through Mar 2026 was $6.4 million, a 22.67% increase from a year earlier, with the FY2025 full-year figure at $5.8 million, up 8.27% from the prior year.
- Total Non-Current Liabilities advanced to $6.4 million in Q1 2026 per SINT's latest filing, from $5.8 million in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $10.1 million in Q4 2022 and bottomed at $4.1 million in Q1 2022.
- The 5-year median for Total Non-Current Liabilities is $5.7 million (2024), against an average of $6.0 million.
- Across the five-year window, Total Non-Current Liabilities surged 134.23% in 2022 and slumped 37.53% in 2023, its largest moves.
- Year by year, Total Non-Current Liabilities stood at $10.1 million in 2022, then slumped by 37.53% to $6.3 million in 2023, then decreased by 15.55% to $5.3 million in 2024, then grew by 8.27% to $5.8 million in 2025, then climbed by 11.7% to $6.4 million in 2026.
- Per Business Quant, the three latest SINT Total Non-Current Liabilities figures stand at $6.4 million (Q1 2026), $5.8 million (Q4 2025), and $6.4 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 20.94 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 41.44 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 41.88 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 2.64 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 3.53 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 9.85 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 24.21 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 3.57 Bn |
| 10 | Sintx Technologies | 17,274.80 | -1.87 Mn | 144,000.00 | 6.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.42 Mn |
| Dec 31, 2025 | 5.75 Mn |
| Sep 30, 2025 | 6.43 Mn |
| Jun 30, 2025 | 5.05 Mn |
| Mar 31, 2025 | 5.24 Mn |
| Dec 31, 2024 | 5.31 Mn |
| Sep 30, 2024 | 5.72 Mn |
| Jun 30, 2024 | 6.44 Mn |
| Mar 31, 2024 | 7.61 Mn |
| Dec 31, 2023 | 6.29 Mn |
| Sep 30, 2023 | 4.75 Mn |
| Jun 30, 2023 | 5.18 Mn |
| Mar 31, 2023 | 6.56 Mn |
| Dec 31, 2022 | 10.07 Mn |
| Sep 30, 2022 | 5.01 Mn |
| Jun 30, 2022 | 5.25 Mn |
| Mar 31, 2022 | 4.13 Mn |
| Dec 31, 2021 | 4.30 Mn |
| Sep 30, 2021 | 4.81 Mn |
| Jun 30, 2021 | 3.64 Mn |